48
Prof. Dr. Robert Riener Sensory-Motor Systems Lab Institute of Robotics and Intelligent Systems, ETH Zurich University Hospital Balgrist, University of Zurich Novel Robots for Gait and Arm Rehabilitation Interview for Advanced Robotic Systems ICRA, Hongkong, 2 nd June 2014

Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Prof. Dr. Robert Riener Sensory-Motor Systems Lab Institute of Robotics and Intelligent Systems, ETH Zurich University Hospital Balgrist, University of Zurich

Novel Robots for Gait and Arm Rehabilitation

Interview for Advanced Robotic Systems ICRA, Hongkong, 2nd June 2014

Page 2: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

SMS Lab: 2 Affiliations, 2 Locations

ETH Zurich University Hospital Balgrist

Spinal Cord Injury Center Institute for Robotics and Intelligent Systems

Page 3: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

For the Therapist ͻ Physically exhausting ͻ Ergonomically

inconvenient

For the Patient ͻ Limited training duration ͻ Gait pattern not optimal

SCI Center, Balgrist University Hospital, Zurich

Disadvantage of Manual Training

Page 4: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Challenges

What Are the Challenges in Rehabilitation?

1. Patients need intensive training to benefit from neuroplastic effects, even in the presence of pharmaceutical factors

2. Number of patients increases due to demographic shift

3. There is a shortage of personnel for rehabilitation and care

=> Chances: Application of Robotics

& Chances

Page 5: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Lokomat Balgrist, Hocoma AG

Robot-Aided Gait Training

Page 6: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Current Robotic Plattforms

for Neurorehabilitation

Page 7: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Gait Rehabilitation "Robots"

Lopes GaitTrainer

Haptic Walker

G-EO

Lokomat

Autoambulator

Page 8: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Hand/Arm Rehabilitation "Robots" MIT Manus Bi-Manu-Track

Haptic Master, GENTLE/s

MGA

Armeo Series ARMin

Page 9: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Pilot study I (n=10)

Single case studies I, chronic stroke (n=3)

ARMin I ARMin II

Pilot study II

Single case studies II, chronic stroke (n=4)

4 Axes 6 Axes

ARMin History

2005 2006 2007 2008 2009 2010 2011 2012

Page 10: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

ARMin History

2005 2006 2007 2008

Pilot study I (n=10)

Single case studies I, chronic stroke (n=3)

ARMin I ARMin II

Pilot study II

Single case studies II, chronic stroke (n=4)

2009 2010 2011

Controlled clinical trial, chronic stroke (n=80)

Pilot study III

ARMin III

Nef, Riener et al. 2006-2011

2012

4 Axes 6 Axes 7 Axes

Page 11: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

ETH Zurich/Balgrist, Hocoma AG

Exoskeletal Robot with 7 Degrees of Freedom

Nef, Riener et al. 2006-2011

ARMin III

Page 12: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Multicenter Randomized Clinical Trial

Hypothesis “Patient-responsive ADL-related robotic training with ARMin is more effective than conventional therapy with respect to motor functional recovery of the affected arm of chronic hemiparetic stroke patients.”

Page 13: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Study Design • Multicenter, randomized, controlled, clinical trial • Four medical centers • Total of 77 patients • Patients with moderate to severe motor impairment of an

upper limb (FMA 8 to 38) after stroke • Chronic state (at least 6 months post-stroke)

Multicenter Randomized Clinical Trial

Page 14: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Primary Outcome • Fugl-Meyer Assessment (FMA), impairment based, upper

arm portion (max. 66 points)

Secondary Outcomes • Wolf Motor Function Test (WMFT)

� time � function

• Questionnaires � Stroke Impact Scale (SIS) � Motor Activity Log (MAL)

• Modified Ashworth-Skala (mAS) • ROM, joint torques measured by ARMin

Study Outcomes

Page 15: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Time Course

Page 16: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Robot (ARMin)

Conventional (Control)

Minimum time 45 min 45 min

Therapy modes Mobilisation (min. 10min)

Mobilisation

Games (min. 10min)

Games

ADL tasks (min. 10min)

ADL tasks

«Others»

Therapy Session Modes

Page 17: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Change in FMA 73 Patients (38 ARMin, 35 Control)

Therapy Follow-up

Klamroth, …, Riener, The Lancet Neurology, Dec. 2013

?

Page 18: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Change in FMA: Severe Cases 34 out of 73 Patients

Therapy Follow-up

Klamroth, …, Riener, The Lancet Neurology, Dec. 2013

Page 19: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

� Patient-responsive ADL-related robotic training with ARMin is more effective than conventional therapy with respect to functional recovery.

� Particularly patients with severe impairment benefit

from robotic therapy of the arm.

� Differences are clinically questionable.

� Were patients “too chronic”? Were robots stimulating too little and supporting too much?

� Future question: Where are the responders?

Conclusion from Clinical Study

Page 20: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

ARMin History

2005 2006 2007 2008

Pilot study I (n=10)

Single case studies I, chronic stroke (n=3)

ARMin I ARMin II

Pilot study II

Single case studies II, chronic stroke (n=4)

2009 2010 2011 ARMin IV

Pilot study IV novel assessment

methods

Controlled clinical trial, chronic stroke (n=80)

Pilot study III

ARMin III

Technology Transfer Armeo®Power Nef, Riener et al. 2006-2011

2012

4 Axes 6 Axes 7 Axes

Page 21: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

ChARMin

ARMin History

2008

s II, 4)

ARMin IV 2009 2010 2011

Pilot study IV novel assessment

methods

Controlled clinical trial, chronic stroke (n=80)

Pilot study III

ARMin III

Technology Transfer Armeo®Power

2012

MR-compatible robotics

2013 2014 …

Page 22: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

ChARMin Setup

U. Keller, R. Riener & KiSpi Zurich

Page 23: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Interaction

Page 24: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Human Machine

Interaction, Cooperation

Page 25: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Key Features ͻ Intensive

Page 26: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Key Features ͻ Intensive ͻ Guided?

Page 27: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Key Features ͻ Intensive ͻ Cooperative ͻ Transparent

Page 28: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Mechanical Interaction

Path Control ͻ Robot behaves assistive,

corrective or transparent, when needed

ͻ Free timing for patient

ͻ Support patient, but do not restrict patient

Duschau-Wicke, Vallery, Riener, et al.

Page 29: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Pos Path_a

-0.2

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

Hf rz

*

Heart Rate

Pos.contr. Path contr.

Muscle Activity

0.06

0.08

0.1

0.12

0.14

0.16

0.18

0.2

0.22

0.24

Nor

mal

ized

mus

cle

activ

ity (B

F)

Position control Path control

Rela

tive

incr

ease

of h

eart

rate

11 incomplete SCI subjects

Path Control Increases Participation

Page 30: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Path Control Enhances Variability

Position Control

-20 -10 0 10 20 30 40 0

10

20

30

40

50

60

70

80

Hip angle [°]

Kne

e an

gle

[°]

Path Control

-20 -10 0 10 20 30 40 0

10

20

30

40

50

60

70

80

Hip angle [°]

Kne

e an

gle

[°]

“Repetition without Repetition” (Bernstein)

Page 31: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Conventional Training

Can be monotonous and boring

Motivation During Gait Training

Page 32: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Gait Training & Virtual Reality

Page 33: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Neuro- plastic effects

Neuro- plastic effects

Engagement Increases Neuroplasticity

Physical activity

Page 34: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Neuro- plastic effects

Neuro- plastic effects

Increased neuro- plastic effects

Engagement Increases Neuroplasticity

Engagement

Physical activity

Mental activity

Page 35: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Key Features ͻ Intensive ͻ Cooperative ͻ Transparent ͻ Engaging ͻ Rewarding

Page 36: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Human-Robot Cooperation

Key Features ͻ Intensive ͻ Cooperative ͻ Transparent ͻ Engaging ͻ Rewarding ͻ Task-specific

Page 37: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Activities of Daily Living Training Chronic Stroke Patient (FMA=26)

Guidali, Riener et al., MBEC 2011

Page 38: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Guidali, Riener et al., MBEC 2011

Activities of Daily Living Training

Page 39: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Social Reward: Tele-Rehabilitation Player RED Uniklinik Balgrist

Player BLUE ETH Zurich

Page 40: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Social Reward: Collaborative Gaming

Page 41: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Outlook & Vision

Page 42: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Problem: Averaging FMA ARMin Group FMA Control Group

Therapy Follow-up Therapy Follow-up

Responder

Non-responder

Page 43: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Distal/ proximal

Challenge: Find the Responders Technical Features Human Subjects

Subject A Subject B Subject C Subject D Subject E Subject F Subject G Subject H Subject J Subject K

Dose (intensity)

ROM

Game, control

Task difficulty

Visual feedback 2D/3D, VR

Auditory feedback

Further displays

Page 44: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Conclusion

Page 45: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

Conclusion

Robots should Cooperate and Motivate • Current robotic approaches often ignore patient activity

• Therapeutic outcome can be increased, when patient is active

• Therefore, future robots should be “patient-cooperative” enhancing patient activity and engagement/reward

Outlook • Implement novel technical features (e.g. provide high intensity

treatment, reward-driven therapy) • Adjust the technology and therapy to find the reponders • Prove effectiveness in clinical studies

Page 46: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin
Page 47: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

General Criteria • Challenge requires actuated devices • Course contains tasks of daily life

Six Different Disciplines

Page 48: Novel Robots for Gait and Arm Rehabilitation · 2009 2010 2011 ARMin IV Pilot study IV novel assessment methods Controlled clinical trial, chronic stroke (n=80) Pilot study III ARMin

The Cybathlon will promote the development of assistive systems for people with disabilities to be suitable for daily use. This should remove barriers between general public, the users and the developers.

Objectives of the Cybathlon

People with Disabilities

Research and Development

General Public